-
1دورية أكاديمية
المؤلفون: Jin J, Okamoto R, Yoon SS, Shih LY, Zhu J, Liu T, Hong XN, Pei L, Rooney B, van de Velde H, Huang HQ
المصدر: OncoTargets and Therapy, Vol Volume 11, Pp 3869-3882 (2018)
مصطلحات موضوعية: Mantle cell lymphoma, bortezomib, VR-CAP, R-CHOP, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: van Keep, Marjolijn, Gairy, Kerry, Seshagiri, Divyagiri, Thilakarathne, Pushpike, Lee, Dawn
مصطلحات موضوعية: Bortezomib, Mantle cell lymphoma, Cost effectiveness, VR-CAP, R-CHOP
-
3
المؤلفون: Ting Liu, Brendan Rooney, Sung Soo Yoon, Lixia Pei, Lee Yung Shih, Huiqiang Huang, Helgi van de Velde, Xiaonan Hong, Rumiko Okamoto, Jun Zhu, Jie Jin
المصدر: OncoTargets and therapy
مصطلحات موضوعية: medicine.medical_specialty, Vincristine, Cyclophosphamide, OncoTargets and Therapy, 03 medical and health sciences, 0302 clinical medicine, Prednisone, Internal medicine, hemic and lymphatic diseases, medicine, Pharmacology (medical), VR-CAP, Adverse effect, mantle-cell lymphoma, Original Research, Bortezomib, business.industry, bortezomib, medicine.disease, Transplantation, Oncology, R-CHOP, 030220 oncology & carcinogenesis, Rituximab, Mantle cell lymphoma, business, 030215 immunology, medicine.drug
وصف الملف: text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e07a837e08c89748f29ec3019c06cdTest
https://pubmed.ncbi.nlm.nih.gov/30013367Test -
4
المصدر: BMC Cancer
مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Vincristine, Cancer Research, Cost effectiveness, Cost-Benefit Analysis, Kaplan-Meier Estimate, Lymphoma, Mantle-Cell, Pharmacology, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Prednisone, Internal medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, medicine, Genetics, Humans, VR-CAP, Cyclophosphamide, Mantle cell lymphoma, business.industry, medicine.disease, United Kingdom, Transplantation, Regimen, 030104 developmental biology, R-CHOP, Doxorubicin, 030220 oncology & carcinogenesis, Rituximab, Female, Quality-Adjusted Life Years, business, medicine.drug, Research Article
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2deabcf620a64af9c78daeae677040bTest